The latest news from Corcept Therapeutics on their Phase 3 GRACE clinical trial clinical trial is excellent. The drug relacorilant significantly reduced high blood pressure and blood sugar levels in people with endogenous Cushing’s syndrome.
Cushing’s
Cushing’s syndrome is a disorder that occurs when your body makes too much of the hormone cortisol over a long period of time. Cortisol is sometimes called the “stress hormone” because it helps your body respond to stress.
October is Pituitary Awareness Month.
From the editor’s desk – For organizations in the pituitary space, we believe it is critically important to reach out to a broader audience to make the case that these conditions, although classified as rare,
Cushing’s disease and syndrome: The evolving story of hypercortisolism
How Cushing’s Disease Helped Shape Sharmyn’s Wonderful Life
On Cushing’s Day, we share Sharmyn McGraw’s blog on her journey with the disease. From her Blog – “Now twenty-one years in remission from a pituitary adenoma tumor, Sharmyn McGraw, patient advocate, author, artist, and
A nice idea for a Cushing’s educational resource
Recordati Rare Diseases, a company dedicated to creating needed therapies for extremely rare and devastating diseases, had an excellent idea of approaching their new educational resource website for Cushing’s disease; they asked patients with Cushing’s
Cortisol levels after Cushing’s surgery
An informal discussion of Cushing’s disease issues from cases, articles, and experiences with patients.
A talk with Crinetics Chairman Scott Struthers, Ph.D.
During these trying times, work continues, even at a faster pace, for new drugs and therapies for pituitary patients. From the J D Faccinetti, co-founder – We recently caught up with Crinetics Pharmaceuticals chairman Dr.
Alternative Cushing’s syndrome treatment
Grzegorz Rosiak, M.D., an interventional radiologist from Warsaw Medical University, sends us a recently published article, “Percutaneous Adrenal Gland Thermal Ablation,” an alternative Cushing syndrome treatment. You can read more about thermal ablation of the adrenal gland
Podcast: A conversation with Dr. Maria Fleseriu
With new advances in the Cushings space, we asked Dr. Maria Fleseriu, Professor of Medicine and Neurological Surgery and Director of the Pituitary Center at Oregon Health and Science University in Portland, Oregon, USA, to give us
More information on Recordati’s new Cushing’s drug Isturisa
In a recent press release, Recordati Rare Diseases announced the results from a Phase III study of Isturisa® (Osilodrostat) published in Lancet Diabetes and Endocrinology. “The exciting data, published today, underscore the efficacy and safety
Doctors’ Response to June News Linking Cortisol Level to Death Risk with COVID-19
From Leslie Edwin, President of CSRF and PWN Contributor – On June 18, 2020, online medical journal The Lancet Diabetes and Endocrinology published a report about the association between high cortisol and death rate with COVID-19.
The complex diagnosis of Cushing’s syndrome
In this engaging podcast about the diagnosis of Cushing’s syndrome, Pituitary Worlds News co-founder and Medical Director, California Center for Pituitary Disorders at UCSF Professor of Clinical Medicine and Clinical Neurological Surgery, Dr. Lewis Blevins
From the European Society of Endocrinology: Cushing’s syndrome clinical management guidance during the COVID-19 Pandemic
This is a series of urgent clinical guidance documents on the management of endocrine conditions in the time of COVID-19. This clinical guidance document underwent expedited open peer review by Jérôme Bertherat (Paris, France), André